Virtus LifeSci Biotech Clinical Trials ETF
16 hedge funds and large institutions have $12.4M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
16
Holders Change
+5
Holders Change %
+45.45%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
